Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.506SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.6.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.438.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.27SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.30SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.188SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.39SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.50SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.501SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.226SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.546SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.194SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.429.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
P.1.9 (Gamma)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.25.1.1 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.203SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.157SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.176SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.3.4 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.391SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.393SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.432SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.388SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
P.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.48SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.515SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.370SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.118SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.137SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.309SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.72SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.108SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.332SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.42.1 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.348SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.428.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.459SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.160.29SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.243.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.566SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.480SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.579SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
N.10SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
P.1.11 (Gamma)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.435SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.445SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.124SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.384SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
XAQSYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.2.3.8SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used